The SLC16A12 gene makes a transporter protein that helps move certain small molecules in the lens of the eye and in the kidneys. When it does not work well, the lens can become cloudy and the kidneys may let glucose pass into the urine. Some inherited variants in the SLC16A12 gene are linked to juvenile cataracts, sometimes along with renal glucosuria. Most people hear about this gene only when early cataracts seem to run in a family.
What is a gene?
A gene is a stretch of DNA that carries information your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do the work. Other genes mostly help determine when certain processes happen, where they take place, and how strongly they operate. Taken together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a more in depth look at this topic, you can find more in the LearnHub.
Overview
SLC16A12Gene function
What if the gene works
The SLC16A12 gene helps move certain small molecules across cell membranes. It is active in the eye lens and kidney, supporting lens clarity and normal handling of substances in urine.
Risk
What if the gene does not work
Variants in the SLC16A12 gene are best known for early cataracts, sometimes with small corneas; some people also have sugar in the urine. Milder and more severe variants can affect when these features appear and how noticeable they are.
Treatment
What does that mean for your treatment
A pathogenic variant in the SLC16A12 gene does not currently change medication choices through any guideline-based, gene-specific treatment plan. Management is guided by the person’s symptoms and routine clinical care, while the SLC16A12 gene is mainly being studied for its role in cataract biology rather than as a current drug target.
Conditions associated with SLC16A12
Gene function
What if the gene works
Your lens and kidneys need a steady flow of small molecules to keep cells balanced. The SLC16A12 gene provides instructions for a membrane transporter, a protein that helps move selected compounds across the cell surface. Understanding SLC16A12 gene function helps explain how these tissues support clear vision and everyday chemical balance.
The SLC16A12 gene helps cells move selected small compounds across the cell membrane. Its protein acts as a controlled doorway, letting these molecules pass in a regulated way.
One well-known job of this transporter is moving creatine, a molecule that helps cells manage short term energy needs. By shifting creatine across membranes, it supports routine energy handling in the tissues where it is active.
In the eye, this transporter is active in lens cells that need a stable internal chemical environment. That steady balance supports the clear structure of the lens during everyday use.
In the kidneys, it helps tubule cells move certain small compounds while urine is being processed. This contributes to normal reabsorption, which means useful substances are taken back into the body instead of being left in urine.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effects and simply represent natural genetic variation. At times, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC16A12 gene can alter the transporter’s shape, stability, or movement to the cell surface, so it may carry substances less effectively or not at all. Studies of how SLC16A12 gene variants affect protein function show a spectrum, with milder changes leaving some activity and more disruptive variants causing a larger loss of function. In families with SLC16A12 related cataracts, greater functional loss may be linked to earlier or more noticeable lens changes.
How variants are linked to conditions
Pathogenic variants in the SLC16A12 gene can cause juvenile cataracts, sometimes together with microcornea and renal glucosuria, a pattern often described as SLC16A12 gene variants linked to cataracts and kidney sugar loss. Some studies have also associated common SLC16A12 variants with age-related cataracts, but those findings reflect risk at a population level and do not mean a person will definitely develop cataracts.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and instead represent normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to the SLC16A12 gene. If a disease-causing change is present, the main issue is the inherited variant itself, and regular eye follow-up can help catch lens changes such as cataracts early.
Inheritance of SLC16A12 variants
For families asking about the inheritance pattern of SLC16A12 gene variants, the best-established pattern is autosomal dominant. This means a person with a disease-causing variant in one copy of the SLC16A12 gene can pass it to a child, and each pregnancy carries a 50% chance of inheriting that variant. Sons and daughters are affected at similar rates because the SLC16A12 gene is on a non-sex chromosome. In many families, the variant is passed from an affected parent to a child across generations.
What does my SLC16A12 result mean for my family?
For SLC16A12, the best-known family pattern is dominant, which means a close relative such as a parent, brother, sister, or child may also carry the same gene change and could have cataracts, small corneas, or related eye findings. In families with a disease-causing SLC16A12 change, each child has a 1 in 2 chance of inheriting it. Some changes can appear for the first time in one family member, so a parent does not always have to be the source.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SLC16A12 gene, genetic testing reads the DNA in a blood or saliva sample. An SLC16A12 genetic test usually uses sequencing to look for changes in the gene, and the result may show no variant, a known disease linked variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the SLC16A12 gene may be worth discussing if you or your child develops cataracts at a young age, especially when cataracts run in the family. It can also be considered when early cataracts come with an unusually small clear front part of the eye.
A genetic result is only one part of your health story
A genetic finding can offer useful insight, but how much it reveals depends on the condition and the kind of variant involved. Lifestyle, environment, age, and medical history are among the many factors that shape how the body functions over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can provide a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly or more quickly than another, which can change how well it works or how likely side effects are. These differences are common and are one reason the same treatment can feel helpful for one person but less effective or harder to tolerate for someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way someone responds to medications. By looking at links between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC16A12 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so general concerns about side effects, new symptoms, or changes in treatment are best discussed with your doctor.
History
The SLC16A12 gene entered the medical literature in the early 2000s as researchers mapped and classified members of the solute carrier family, a large group of genes involved in moving small substances in the body. It was also described as MCT12 during this period, reflecting how scientists first grouped it with related transport genes. A few years later, family studies linked variants in the SLC16A12 gene to inherited cataracts, which brought the gene into clearer clinical focus. From these first observations, research expanded steadily. Later studies also explored whether common variants near the SLC16A12 gene might influence age related cataract risk in the wider population. Over time, descriptions became more precise as genetic testing connected this gene with specific inherited eye conditions.